Eye
Reproductive health and childbirth
Assessing Physiological Risk Factors for Retinopathy of Prematurity (ROP) Progression and Effects of Anti-VEGF Therapy on Neurodevelopment: PROGRESS-ROP Study
1 in 3 babies born prematurely before 32 weeks are at risk of developing retinopathy of prematurity (ROP), a condition caused by abnormal growth of blood vessels in the retina. ROP is a leading cause of childhood blindness worldwide and can significantly impact a child’s quality of life. In 2010, a clinical trial showed that a treatment called anti-VEGF, which works by stopping abnormal blood vessel growth, is effective in treating ROP. As a result, it has been widely used ...
GO TO STUDY